Current stock page

Financial Data

VSTM Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

VSTMVerastem, Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

NeutralEdge 6/10
$8.18−$0.26 (−3.08%)

Latest quote

  • Momentum
    89
  • Value
    53
  • Quality
    42
  • Risk resilience
    36
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$24.01M$40.08M$18.67M$17.54M$11.24M$2.14M$0$0
Gross Profit$20.07M$36.04M$15.62M$14.64M$9.57M$1.69M$0$0
Operating Income-$75.22M-$32.71M-$44.9M-$41.47M-$40.72M-$43.76M-$44.17M-$31.59M
Net Income-$74.72M-$34.67M-$36.59M-$32.92M-$98.52M-$25.93M-$52.1M-$64.55M
EPS-$0.74-$0.35-$0.37-$0.39-$1.35-$0.39-$0.96-$1.7
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$33.59M-$43.91M-$52.12M-$29.95M-$36.22M-$32.66M-$38.68M-$25.1M
Capital Expenditure$0$0$0-$1.35M$0$0$0$0
Free Cash Flow-$33.59M-$43.91M-$52.12M-$31.3M-$36.22M-$32.66M-$38.68M-$25.1M
Net Cash Provided By Operating Activities-$33.59M-$43.91M-$52.12M-$29.95M-$36.22M-$32.66M-$38.68M-$25.1M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$229.64M$206.51M$227.81M$246.44M$176.85M$196.26M$131.7M$101.54M
Total Debt$122.12M$84.33M$85.48M$87.17M$89.48M$84.72M$76.8M$42.25M
Cash And Cash Equivalents$172.8M$136.35M$165.55M$204.99M$137.71M$164.32M$117.57M$88.82M
Total Liabilities$219.54M$156.53M$146.03M$189.25M$192.38M$160.21M$164.13M$130.43M
Total Stockholders Equity$10.1M$49.99M$81.78M$57.2M-$15.53M$36.06M-$32.43M-$28.89M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio84.2911.846.868.47—11.54——
P/S ratio8.26———————
Debt To Equity12.091.691.051.52—2.35——
Free Cash Flow Yield-18.90%-27.64%-27.14%-28.66%-22.92%-28.90%-28.49%-40.45%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio84.2911.846.868.47—11.54——
P/S ratio8.26———————
Return On Equity-17.71%-4.06%-237.18%-3.66%—-4.62%——
Debt To Equity12.091.691.051.52—2.35——

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-4.42x
Pb81.98x
Revenue Growth Yoy113.59%
EPS Growth Yoy45.19%
Gross Margin86.11%
Operating Margin-193.73%
ROE-359.49%
ROIC-145.58%
Debt To Equity12.09
FCF Yield-15.61%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$8.18
Volume1.72M
RSI (14)41.63
MACD0.02
MACD signal0.23
MACD histogram-0.21
ADX (14)28.32
SMA (50)$8.49
SMA (200)$6.30
ATR (14)$0.66
Historical volatility (annualized)72.35%
Volume (20-day average)3.29M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score36/100
Beta0.89
Annual volatility74.24%
Max Drawdown-67.58%
Sharpe Ratio0.32
VaR (95%, 1-day)-7.18%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

VSTM Financial Data FAQ

What is Verastem, Inc.'s revenue?

Verastem, Inc.'s revenue is one of the core financial data points for VSTM. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Verastem, Inc.'s revenue growing?

Revenue growth shows whether Verastem, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is VSTM's EPS?

VSTM's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Verastem, Inc.'s net income?

Verastem, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Verastem, Inc. generate?

Free cash flow shows how much cash Verastem, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Verastem, Inc. have?

Cash and debt help frame VSTM's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.